Phoenix Biotech Acquisition - Units (1 Ord Class A & 1/2 War) Net Tangible Assets

As of the most recent data (June 2026), PBAXU shows a net tangible assets of $-31M. That compares with $-1.6M in the prior-year period — down 1767.0% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, PBAXU's net tangible assets is now $-31M (was $-1.6M) — a 1767.0% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Phoenix Biotech Acquisition - Units (1 Ord Class A & 1/2 War) is outperforming or lagging.

Tracking PBAXU's net tangible assets over time shows whether Phoenix Biotech Acquisition - Units (1 Ord Class A & 1/2 War) is scaling, shrinking, or reshaping that part of the business. The current reading is $-31M That compares with $-1.6M in the prior-year period — down 1767.0% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this net tangible assets page, Stockcircle has Phoenix Biotech Acquisition - Units (1 Ord Class A & 1/2 War)'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect net tangible assets (currently $-31M) with ownership activity and broader fundamentals.